New drug may help gut wake up faster after colon surgery
NCT ID NCT07271875
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a newer drug, sugammadex, helps the bowels recover faster after colorectal surgery compared to an older drug combination (neostigmine/atropine). 560 adults having elective colorectal surgery will be randomly assigned to receive one of the two drugs at the end of surgery. The main goal is to see if more patients in the sugammadex group regain normal bowel function within 72 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sugammadex and Neostigmine + Atropine
- What this could lead to
- If sugammadex works better, it could mean faster bowel recovery, less nausea, and shorter hospital stays after colorectal surgery.
- What could go wrong
- This is a single-center trial that hasn't started yet. Results may not apply to all hospitals, and the benefit over standard care may be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?